Luke Timmerman @luketimmerman.bsky.social · 20/08/20269 Young Scientists to Watch. timmermanreport.com/2026/08/9-yo... 000
Luke Timmerman @luketimmerman.bsky.social · 03/03/2026T-cell engagers for autoimmune disease. Listen to Ken Song, CEO of San Diego-based Candid Therapeutics, on The Long Run podcast. Sponsored by @alphasenseinc.bsky.social & Dash Bio. timmermanreport.com/2026/03/t-ce...timmermanreport.comT-cell Engagers for Autoimmune Disease: Ken Song on The Long Run - TimmermanReport.comKen Song is today’s guest on The Long Run. First things first, this episode was recorded before news broke that Candid Therapeutics went public via a reverse merger with RallyBio. But I must say, that... 031
Luke Timmerman @luketimmerman.bsky.social · 26/01/2026Science and Industry Need to Push Back Hard. Guest editorial by @cdelawalla.bsky.social @standupforscience.bsky.social timmermanreport.com/2026/01/scie... 142
Luke Timmerman @luketimmerman.bsky.social · 09/09/2025Next stop: Kilimanjaro 2026 for Damon Runyon Cancer Research Foundation Meet the team of biotech leaders raising $1 million for cancer research and hiking up the highest peak in Africa. timmermanreport.com/2025/09/next...timmermanreport.comNext Stop: Kilimanjaro 2026 for Damon Runyon Cancer Research - TimmermanReport.comThe biotech industry can do amazing things when concentrated on an audacious goal. Like curing cancer. I’m fired up to announce the next Timmerman Traverse for Damon Runyon Cancer Research Foundation.... 051
Luke Timmerman @luketimmerman.bsky.social · 04/09/2025Why is Vineeta Agarwala joining the Timmerman Traverse for a 3rd time on Oct. 4? Watch. 030
Luke Timmerman @luketimmerman.bsky.social · 25/08/2025Timmerman Traverse for Life Science Cares raises another $1.1M to fight poverty. timmermanreport.com/2025/08/timm...timmermanreport.comTimmerman Traverse for Life Science Cares Raises Another $1.1M to Fight Poverty in 2025 - TimmermanReport.comAnother Timmerman Traverse for Life Science Cares is in the books. This year, we raised $1.15 million from more than 1,000 donors to fight poverty in biotech hubs around the US. We raised awareness of... 031
Luke Timmerman @luketimmerman.bsky.social · 06/08/2025CAR-T cells against solid tumors. Listen to Sabah Oney, CEO of Dispatch Biotherapeutics, on The Long Run. timmermanreport.com/2025/08/car-...timmermanreport.comCAR-T Cells Against Solid Tumors: Sabah Oney on The Long Run - TimmermanReport.comSabah Oney is today’s guest on The Long Run. Sabah is the CEO of Philadelphia and San Francisco-based Dispatch Biotherapeutics. This startup is developing engineered CAR-T cell therapies for solid tum... 011
Luke Timmerman @luketimmerman.bsky.social · 05/08/2025VIDEO: Conversation with Phil Sharp and Bill Haney about 'Cracking the Code.' Documentary film about an inspiring life in science. timmermanreport.com/2025/08/vide...timmermanreport.comVIDEO: Phil Sharp and Bill Haney on 'Cracking the Code' - TimmermanReport.comScience and society have always had an uneasy relationship. Yet there are always people out there seeking to build bridges of understanding. I recently moderated a conversation at MIT with Phil Sharp... 031
Luke Timmerman @luketimmerman.bsky.social · 23/07/2025Creative Ways to Back Young Scientists. Listen to Yung Lie and Andy Rachleff of Damon Runyon Cancer Research Foundation on The Long Run podcast. timmermanreport.com/2025/07/crea...timmermanreport.comCreative Ways to Back Young Scientists: Andy Rachleff and Yung Lie on The Long Run - TimmermanReport.comYung Lie and Andy Rachleff are today’s guests on The Long Run. Yung is the president and CEO of the Damon Runyon Cancer Research Foundation, based in New York. Andy is the board chair. Andy was one of... 021
Luke Timmerman @luketimmerman.bsky.social · 26/06/2025Sublime scenery. Smiling faces. Thanks to the sponsors of the Timmerman Traverse for Damon Runyon Cancer Research Foundation. Watch this for 90 seconds of joy. www.youtube.com/watch?v=LwzE...youtube.comThank you to the sponsors of the 2025 Timmerman Traverse to Everest Base Camp!YouTube video by Damon Runyon Cancer Research Foundation 000
Luke Timmerman @luketimmerman.bsky.social · 12/06/2025Finding Therapies in Long Non-Coding RNA. John Rinn of University of Colorado and Lincswitch Therapeutics is the latest guest on The Long Run. Available on Apple Podcasts, Spotify, and YouTube. timmermanreport.com/2025/06/find...timmermanreport.comFinding Therapies in Long Non-Coding RNA: John Rinn on The Long Run - TimmermanReport.comJohn Rinn is today’s guest on The Long Run. John is the Leslie Orgel and Marvin Caruthers professor of RNA science at the University of Colorado in Boulder. His research is focused on long non-coding ... 001
Luke Timmerman @luketimmerman.bsky.social · 11/06/2025Join me at 3 pm Mon. June 16 at the BIO International Convention's Storytelling Stage to hear about the past, present, and future of Timmerman Traverse for @lifesciencecares.bsky.social @damonrunyon.org convention.bio.org/program/bio-...convention.bio.orgBIO International Convention | Storytelling StageExperience powerful stories from researchers, patients, and innovators at the BIO 2025 Storytelling Stage, June 16–19 in Boston. 011
Luke Timmerman @luketimmerman.bsky.social · 05/06/2025Request an Invitation to the Timmerman Traverse. timmermanreport.com/2025/06/requ...timmermanreport.comRequest an Invitation to the Timmerman Traverse - TimmermanReport.comTimmerman Traverse is looking for a few good men and women. Opportunities are here for people who are physically fit, enjoy nature, thrive in community, and who want to roll up the sleeves for worthy ... 000
Luke Timmerman @luketimmerman.bsky.social · 29/05/2025A New (and Old) Idea for Cardiovascular Disease & Diabetes. @ethanjweiss.bsky.social and Josh Lehrer of Marea Therapeutics are the latest guests on The Long Run. timmermanreport.com/2025/05/a-ne...timmermanreport.comA New and Old Idea for Cardiovascular Disease & Diabetes: Ethan Weiss & Josh Lehrer on The Long Run - TimmermanReport.comEthan Weiss and Josh Lehrer are today’s guests on The Long Run. Ethan is the co-founder and chief scientific officer of South San Francisco-based Marea Biosciences. Josh is the CEO. They are seeking t... 010
Luke Timmerman @luketimmerman.bsky.social · 27/05/2025Reclaiming Biotech's Edge: In Defense of Taking Disciplined Risk. Guest editorial by Anika Gupta Vatsa. timmermanreport.com/2025/05/recl... 010
Luke Timmerman @luketimmerman.bsky.social · 23/05/2025Timmerman Traverse for @lifesciencecares.bsky.social is at $535,178 in pending and closed donations. Halfway to the $1M team goal with three months to go. Thanks to major sponsors Fenwick & West, KCap Biotechnology Fund and HSBC Innovation Banking. Looking forward to our PNW adventure! 020
Luke Timmerman @luketimmerman.bsky.social · 14/05/2025Biologic Drug Discovery Made Faster. Peyton Greenside of BigHat Biosciences is the latest guest on The Long Run podcast. timmermanreport.com/2025/05/biol...timmermanreport.comBiologic Drug Discovery Made Faster: Peyton Greenside on The Long Run - TimmermanReport.comPeyton Greenside is today’s guest on The Long Run. Peyton is the co-founder and CEO of San Mateo, Calif.-based BigHat Biosciences. The company was started in 2019 to build on advances in synthetic bio... 051
Luke Timmerman @luketimmerman.bsky.social · 02/05/2025A Sublime Experience. See the photo highlights of Timmerman Traverse for Damon Runyon Cancer Research Foundation. timmermanreport.com/2025/05/a-su...timmermanreport.comA Sublime Experience: Views of Timmerman Traverse for Damon Runyon Cancer Research - TimmermanReport.comKathmandu, Nepal We did it together. The Timmerman Traverse for Damon Runyon Cancer Research Foundation completed a splendid expedition to Everest Base Camp on Apr. 23, 2025. This trip succeeded on ev... 031
Luke Timmerman @luketimmerman.bsky.social · 24/04/2025We all made it! The Timmerman Traverse for Damon Runyon Cancer Research Foundation team arrived at Everest Base Camp (elev. 17,600 feet) on Apr. 23, 2025. Another awe-inspiring day in the mountains, supporting brave and bold cancer research. Thanks to all who supported this marvelous experience. 1181
Luke Timmerman @luketimmerman.bsky.social · 21/04/2025Views from Day 7 of Timmerman Traverse for Damon Runyon Cancer Research Foundation. 000
Luke Timmerman @luketimmerman.bsky.social · 19/04/2025Stunning views from Timmerman Traverse for Damon Runyon Cancer Research Foundation. Day 5. We’re at Dingboche, elevation 14,300 ft. The Himalayas in full glory. 0121
Luke Timmerman @luketimmerman.bsky.social · 10/04/2025What US Biotech Can Do to Meet the Moment. By David Li, CEO of SF-based Meliora Therapeutics. timmermanreport.com/2025/04/a-ne... 020
Reposted by Luke TimmermanCarolyn Bertozzi @carolynbertozzi.bskyverified.social · 09/04/2025Great article by @nobelprize.bsky.social laureate @ardemp.bskyverified.social outlining the health, economic and national security benefits of US biomedical research, and the devastation of government efforts to destroy our leading edge. www.cnn.com/2025/04/09/h...cnn.comNobel laureate: I owe America my success. Today, its scientific future is in danger | CNNDr. Ardem Patapoutian says he watches “with deep sadness as the United States’ remarkable scientific enterprise, which took generations of hard work and national investment to build, faces a concerted... 211549
Luke Timmerman @luketimmerman.bsky.social · 09/04/2025Dr. Larry Corey was a fan of the Superman comics as a kid. Now he's looking for a hero in a red cape to stand up for mRNA vaccines and therapies. timmermanreport.com/2025/04/we-n...timmermanreport.comWe Need an mRNA Champion in a Red Cape - TimmermanReport.comI grew up in an era of Superman comic books. Superman captivated the imagination of a generation of kids like me. It told stories of an otherwise ordinary human who could achieve extraordinary feats o... 012
Luke Timmerman @luketimmerman.bsky.social · 08/04/2025A favorite sign from the Saturday rally in Seattle. 020
Luke Timmerman @luketimmerman.bsky.social · 07/04/2025Meet the 2025 Timmerman Traverse for Life Science Cares 2025 team. Men and women on a mission to raise $1 million to fight poverty in BOS, SF, SD, PHI and NYC. Top sponsor: Fenwick & West. CC @robperez.bsky.social timmermanreport.com/2025/04/meet...timmermanreport.comMeet the Timmerman Traverse for Life Science Cares 2025 Team - TimmermanReport.comThe 5th annual Timmerman Traverse for Life Science Cares is fired up and ready for outdoor adventure in 2025. We’re on a mission to raise $1 million to fight poverty. This year’s team is preparing fo... 010
Luke Timmerman @luketimmerman.bsky.social · 03/04/2025Goal: the 2025 Timmerman Traverse for Damon Runyon Cancer Research Foundation has hit the fundraising goal of $700,000 for high-risk / high-reward cancer research. Team gearing up for trek to Everest Base Camp. timmermanreport.com/2025/04/timm...timmermanreport.comTimmerman Traverse for Damon Runyon Hits $700K Goal, Fueling Cancer Research - TimmermanReport.comTimes are tough in biotech, but this is an industry where we learn, adapt, and move forward. I’m proud to announce that the 2025 Timmerman Traverse for Damon Runyon Cancer Research Foundation has hit ... 020
Luke Timmerman @luketimmerman.bsky.social · 31/03/2025Longevity is Having a Moment, and the Secret Weapon of GLP1 Weight Loss Medicines. Two smart new pieces by @dshaywitz.bsky.social timmermanreport.com/2025/03/long... timmermanreport.com/2025/03/glp-...timmermanreport.comLongevity Is Having A Moment - TimmermanReport.comDying, with few exceptions, has never been especially popular, and our shared interest in not dying hardly constitutes breaking news. Nevertheless, the aspiration of living longer — and remaining hea... 021
Luke Timmerman @luketimmerman.bsky.social · 28/03/2025A Moment of Peril and Promise. (Sub. Req.) timmermanreport.com/2025/03/sole...timmermanreport.comA Moment of Peril and Promise - TimmermanReport.comPlease subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, a... 000
Luke Timmerman @luketimmerman.bsky.social · 25/03/2025I'll be in Boston tomorrow to interview George Church, Abbie Celniker, and Bruce Booth at the MassBio State of Possible conference. @massbio.bsky.social. www.massbio.org/state-of-pos...massbio.orgThe State of Possible Conference - MassBioJoin industry leaders at the State of Possible Conference 2025 on March 26, hosted by MassBio in Boston. Discover insights on the future of biotech, pharma, and innovation in the Massachusetts life sc... 020
Luke Timmerman @luketimmerman.bsky.social · 24/03/2025NIH Cuts Threaten to Cede US Life Science Dominance to China. Guest editorial by state biotech leaders from Ohio, North Carolina, Washington and Michigan. timmermanreport.com/2025/03/nih-... 153
Luke Timmerman @luketimmerman.bsky.social · 24/03/2025How a Dark Horse Candidate Is Upending the Sequencing Market. By Joe Horsman, biotech investor at Madrona. timmermanreport.com/2025/03/how-... 040
Luke Timmerman @luketimmerman.bsky.social · 19/03/2025See the photos from the TR10 West party. timmermanreport.com/2025/03/see-...timmermanreport.comSee the Photos from TR10 West - TimmermanReport.comThanks to everyone who attended the TR10 anniversary party Mar. 13 at Adaptive Biotechnologies. The toasts and roasts were funny, perceptive and heartfelt. It was a joyous occasion. Enjoy a few photos... 030
Luke Timmerman @luketimmerman.bsky.social · 19/03/2025See the photos from the TR10 East party. timmermanreport.com/2025/03/see-...timmermanreport.comSee the Photos from TR10 East - TimmermanReport.comThanks to everyone who attended the TR10 anniversary party Mar. 6 at Alnylam Pharmaceuticals. The toasts and roasts were funny, perceptive and heartfelt. There was a joyful community spirit in the roo... 021
Luke Timmerman @luketimmerman.bsky.social · 18/03/2025Why cell & gene therapy companies should talk with RFK Jr. Guest editorial by Tim Hunt, CEO of Alliance for Regenerative Medicine. timmermanreport.com/2025/03/why-... 000
Luke Timmerman @luketimmerman.bsky.social · 18/03/2025Arbor Survives Winter, Gets $73.9M to Take Gene Editing Therapy to the Clinic. timmermanreport.com/2025/03/arbo... 000
Luke Timmerman @luketimmerman.bsky.social · 17/03/2025The new frontier of CAR-T cell therapies made in the body. Listen to Andy Scharenberg, CEO of Umoja Biopharma, on The Long Run. timmermanreport.com/2025/03/car-...timmermanreport.comCAR-T cell Therapies Made In the Body: Andy Scharenberg on The Long Run - TimmermanReport.comAndy Scharenberg is today’s guest on The Long Run. Andy is the co-founder and CEO of Seattle-based Umoja Biopharma. The company is developing in vivo CAR-T cell therapies. The idea is to use gene ther... 030
Luke Timmerman @luketimmerman.bsky.social · 14/03/2025Wonderful to see Brad Loncar and so many friends and supporters at the TR10 West Coast party last night. It's rough out there. But there's still plenty to be thankful for and celebrate in the biotech community. www.biotechtv.com/post/timmerm...biotechtv.comCongratulations to Luke Timmerman on 10 years of Timmerman ReportCelebrating with the Seattle (and beyond) biotech community. 050
Luke Timmerman @luketimmerman.bsky.social · 12/03/2025NIH cuts are hitting young scientists the hardest. By David Baker. timmermanreport.com/2025/03/davi... 02222
Luke Timmerman @luketimmerman.bsky.social · 10/03/2025Standing up for Science. A report from the rally in Seattle by Arjun Kumar. timmermanreport.com/2025/03/scie...timmermanreport.comScientists Standing Up in Seattle - TimmermanReport.comSeveral thousand scientists gathered Friday in Seattle for one of the nationwide “Stand Up for Science” protests. People studying a range of disciplines — biology, climate change, public health and mo... 000
Luke Timmerman @luketimmerman.bsky.social · 03/03/2025Technology to Accelerate Drug Discovery. Najat Khan of @recursionpharma.bsky.social is the latest guest on The Long Run. timmermanreport.com/2025/03/a-wo...timmermanreport.comA Woman in the TechBio Arena: Najat Khan on The Long Run - TimmermanReport.comNajat Khan is today’s guest on The Long Run. She is the chief R&D and chief commercial officer of Salt Lake City-based Recursion. The company is one of the first-generation companies that have sought ... 000
Luke Timmerman @luketimmerman.bsky.social · 26/02/2025How to Know When a Company Should Throw in the Towel. By Alex Harding. timmermanreport.com/2025/02/how-... 000
Luke Timmerman @luketimmerman.bsky.social · 24/02/2025Good interview. www.sciencefriday.com/segments/aaa...sciencefriday.comMaking Sense Of Federal Cuts To Science—And What Comes NextThe CEO of one of America’s oldest scientific societies discusses the recent cuts to scientific institutions, and how scientists can respond. 000
Luke Timmerman @luketimmerman.bsky.social · 24/02/2025Defend Young Scientists. timmermanreport.com/2025/02/stan...timmermanreport.comDefend Young Scientists - TimmermanReport.comBiotech thrives on the creative dynamism of young scientists. Always has. Young scientists are under pressure. NIH grants are on hold. If the NIH budget is gutted, and a generation is forced to find o... 030
Luke Timmerman @luketimmerman.bsky.social · 18/02/2025Defend the FDA. timmermanreport.com/2025/02/defe...timmermanreport.comDefend the FDA - TimmermanReport.comWe need a competent, well-supported, tough and independent food and drug regulator in this country. We need that independent cop on the beat so we can have confidence that the medicines, vaccines, dia... 1121
Luke Timmerman @luketimmerman.bsky.social · 17/02/2025Zero-Toll Medicine. Thought-provoking guest editorial by D.A. Wallach. timmermanreport.com/2025/02/zero... 000
Luke Timmerman @luketimmerman.bsky.social · 13/02/2025Defend the NIH. timmermanreport.com/2025/02/defe...timmermanreport.comDefend the NIH - TimmermanReport.comToo many people don’t believe anymore in the American Dream. But if you can’t dream big, you can’t accomplish big things. Today, the National Institutes of Health — biomedical science itself — is unde... 098
Luke Timmerman @luketimmerman.bsky.social · 12/02/2025Building a fully-integrated biopharma company for muscle disorders. Robert Blum of Cytokinetics is the latest guest on The Long Run. Sponsored by Chordoma Foundation. timmermanreport.com/2025/02/buil...timmermanreport.comBuilding a Fully Integrated Biopharma For the Muscle: Robert Blum on The Long Run - TimmermanReport.comRobert Blum is today’s guest on The Long Run. Robert is the CEO of South San Francisco-based Cytokinetics. He joined the company back in the beginning in 1998 and became CEO in 2007. This company, and... 020
Luke Timmerman @luketimmerman.bsky.social · 11/02/2025Speaking up for science, even when inconvenient. By Steve Holtzman, retired biotech CEO, Nov. 21. timmermanreport.com/2024/11/spea... 000
